Glucose utilization and production in patients with maturity-onset diabetes of the young caused by a mutation of the hepatocyte nuclear factor- 1α gene

Diabetes

Volumn 47, Issue 9, 1998, Pages 1459-1463

  Surmely, Jean François ^a   Guenat, Eliane ^a   Philippe, Jacques ^b   Dussoix, Philippe ^b   Schneiter, Philippe ^a   Temler, Evelyne ^c   Vaxillaire, Martine ^d   Froguel, Philippe ^d   Jéquier, Eric ^a   Tappy, Luc ^a  

^a UNIVERSITY OF LAUSANNE   (Switzerland)

^b GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^c LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^d LILLE UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEAR FACTOR I;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; GENE MUTATION; GLUCOSE BLOOD LEVEL; GLUCOSE METABOLISM; HUMAN; HYPERGLYCEMIA; MALE; MATURITY ONSET DIABETES MELLITUS; PRIORITY JOURNAL;

EID: 0031702434     PISSN: 00121797     EISSN: None     Source Type: Journal    
DOI: 10.2337/diabetes.47.9.1459     Document Type: Article

References (31)

1. Fajans SS: Scope and heterogeneous nature of MODY. Diabetes Care 13:49-64, 1990
2. Yamagata K, Oda N, Kaisaki PJ, Menzel S, Furuta H, Vaxillaire M, Southam L, Cox RD, Lathrop GM: Mutations in the hepatocyte nuclear factor-lα gene in maturity-onset diabetes of the young (MODY3). Nature 384:455-458, 1996
3. Froguel P, Zouali H, Vionnet N, Velho G, Vaxillaire M, Sun F, Lesage S, Stoffel M, Takeda J, Passa P, Permutt A, Beckmann JS, Bell GI, Cohen D: Familial hyperglycemia due to mutations in glucokinase: definition of a subtype of diabetes mellitus. N Engl J Med 328:697-702, 1993
4. Yamagata K, Furuta H, Oda N, Kaisaki PJ, Menzel S, Cox NJ, Fajans SS, Sig norini S, Stoffel M, Bell GI: Mutations in the hepatocyte nuclear factor-4α gene in maturity-onset diabetes of the young (MODY1). Nature 384:458-460, 1996
5. Vaxillaire M, Rouard M, Yamagata K, Oda N, Kaisaki PJ, Boriraj W, Chevre JC, Boccio V, Cox RD, Lathrop GM, Dussoix P, Philippe J, Timsit J, Charpentier G, Velho G, Bell GI, Froguel P: Identification of nine novel mutations in the hepatocyte nuclear factor 1 alpha gene associated with maturity-onset diabetes of the young (MODY3). Hum Mol Genet 6:583-586, 1997
6. Dussoix P, Vaxillaire M, Iynedjian PB, Tiercy JM, Ruiz J, Spinas GA, Berger W, Zahnd G, Froguel P, Philippe J: Diagnostic heterogeneity of diabetes in lean young adults: classification based on immunological and genetic parameters. Diabetes 46:622-631, 1997
7. DeFronzo RA: The triumvirate; β-cell, muscle, liver: a collusion responsible for NIDDM. Diabetes 37:667-687, 1988
8. Byrne MM, Sturis J, Clement K, Vionnet N, Pueyo ME, Stoffel M, Takeda J, Passa P, Cohen D, Bell GI, Velho G, Froguel P, Polonsky KS: Insulin secretory abnormalities in subjects with hyperglycemia due to glucokinase mutations. J Clin Invest 93:1120-1130, 1994
9. Velho G, Petersen KF, Perseghin G, Hwang JH, Rothman DL, Pueyo ME, Cline GW, Froguel P, Shulman GI: Impaired hepatic glycogen synthesis in glucokinase-deficient (MODY-2) subjects. J Clin Invest 98:1755-1761, 1996
10. Tappy L, Dussoix P, Iynedjian P, Henry S, Schneiter P, Zahnd G, Jéquier E, Philippe J: Abnormal regulation of hepatic glucose output in maturity-onset diabetes of the young caused by a specific mutation of the glucokinase gene, Diabetes 46:204-208, 1997
11. Courtois G, Baumhueter S, Crabtree GR: Purified hepatocyte nuclear factor 1 interacts with a family of hepatocyte-specific promoters. Proc Natl Acad Sci US A 85:7937-7941, 1988
12. Ktistaki E, Talianidis I: Modulation of hepatic gene expression by hepatocyte nuclear factor 1. Science 277:109-112, 1997
13. Miquerol L, Lopez S, Cartier N, Tulliez M, Raymondjean M, Kahn A: Expression of the L-type pyruvate kinase gene and the hepatocyte nuclear factor 4 transcription factor in exocrine and endocrine pancreas. J Biol Chem 269:8944-8951, 1994
14. Emens LA, Landers DW, Moss LG: Hepatocyte nuclear factor la is expressed in a hamster insulinoma line and transactivates the rat insulin I gene. Proc Natl Acad Sci USA 89:7300-7304, 1992
15. Lento M, Tuomi T, Mahtani MM, Widén E, Forsblom C, Sarelin L, Gullström M, Isomaa B: Characterization of the MODY3 phenotype: early-onset diabetes caused by an insulin secretion defect J Clin Invest 99:582-591, 1997
16. Byrne MM, Sturis J, Menzel S, Yamagata K, Fajans SS, Dronsfield MJ, Bain SC, Hattersley AT, Vehlo G, Froguel P, Bell GI, Polonsky KS: Altered insulin secretory responses to glucose in diabetic and nondiabetic subjects with mutations in the diabetes susceptibility gene MODY3 on chromosome 12. Diabetes 45:1503-1510, 1996
17. Herman WH, Fajans SS, Ortiz FJ, Smith MJ, Sturis J, Bell GI, Polonsky KS, Halter JB: Abnormal insulin secretion, not insulin resistance, is the genetic or primary defect of MODY in the RW pedigree. Diabetes 43:40-46, 1994
18. DeFronzo RA, Tobin JD, Andres R: Glucose clamp technique: a method for quantifying insulin secretion and resistance. Am J Physiol 237:E214-E223, 1979
19. Jallut D, Tappy L, Kohut M, Bloesch D, Munger R, Schutz Y, Chioléro R, Felber JP, Livio JJ, Jéquier E: Energy balance in elderly patients after surgery for a femoral neck fracture. J Parenter Enter Nutr 14:563-568, 1990
20. Livesey G, Elia M: Estimation of energy expenditure, net carbohydrate utilization, and net fat oxidation and synthesis by indirect calorimetry: evaluation of errors with special reference to the detailed composition of foods. Am J Clin Nutr 47:608-628, 1988
21. DeFronzo RA, Soman V, Sherwin RS, Hendler R, Felig P: Insulin binding to monocytes and insulin action in human obesity, starvation, and refeeding. J Clin Invest 62:204-213, 1978
22. Finegood DT, Bergman RN, Vranic M: Estimation of endogenous glucose production during hyperinsulinemic euglycemic glucose clamps: comparison of labeled and unlabeled glucose infusates. Diabetes 36:914-924, 1987
23. Hohorst H: Lactate. In Methods of Enzymatic Analysis. Bergmeyer H, Ed. New York, Academic, 1965, p. 266
24. DeFronzo RA, Ferrannini E, Simonson DC: Fasting hyperglycemia in noninsulin-dependent diabetes mellitus: contributions of excessive hepatic glucose production and impaired tissue glucose uptake. Metabolism 38:387-395, 1989
25. Fery F: Role of hepatic glucose production and glucose uptake in the pathogenesis of fasting hyperglycemia in type 2 diabetes: normalization of glucose. J Clin Endocrinol Metab 78:536-542, 1994
26. Chen YD, Swislocki AL, Jeng CY, Juang JH, Reaven GM: Effect of time on measurement of hepatic glucose production. J Clin Endocrinol Metab 67:1084-1088, 1988
27. Tappy L, Acheson K, Curchod B, Schneiter P, Normand S, Pachiaudi C, Riou JP, Jéquier E: Overnight glucose metabolism in obese non-insulin-dependent diabetic patients and in healthy lean individuals. Clin Physiol 14:251-265, 1994
28. Campbell P, Mandarine L, Gerich J: Quantification of the relative impairment in actions of insulin on hepatic glucose production and peripheral glucose uptake in non-insulin-dependent diabetes mellitus. Metabolism 37:15-21, 1988
29. Groop LC, Bonadonna RC, DelPrato S, Ratheiser K, Zyck K, Ferrannini E, DeFronzo RA: Glucose and free fatty acid metabolism in non-insulin-dependent diabetes mellitus. J Clin Invest 84:205-213, 1989
30. Iynedjian PB, Marie S, Gjinovci A, Genin B, Deng S-P, Buhler L, Morel P, Mentha G: Glucokinase and phosphoenolpyruvate carboxykinase (GTP) in the human liver: regulation of gene expression in cultured hepatocytes. J Clin Invest 95:1966-1973, 1995
31. Yki-Järvinen H: Glucose toxicity. Endocr Rev 13:415-431, 1992